| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| QDEL - Quidel Corporation | HOLD | 0 @ USD 27.53 | USD 0 | The current share valuation price of QDEL based on adjusted close was USD 27.53. The average price that QDEL shares were previous bought at was USD 34.337. The current market price is -19.8% lower than average price they were purchased at. The value of the holding in QDEL has increased by USD 9,527 compared to the previous valuation of Quidel Corporation however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| LMAT - LeMaitre Vascular Inc | HOLD | 0 @ USD 84.9201 | USD 0 | The current share valuation price of LMAT based on adjusted close was USD 84.9201. The average price that LMAT shares were previous bought at was USD 88.5551. The current market price is -4.1% lower than average price they were purchased at. The value of the holding in LMAT has increased by USD 3,662 compared to the previous valuation of LeMaitre Vascular Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| MASI - Masimo Corporation | HOLD | 0 @ USD 138.09 | USD 0 | The current share valuation price of MASI based on adjusted close was USD 138.09. The average price that MASI shares were previous bought at was USD 154.973. The current market price is -10.9% lower than average price they were purchased at. The value of the holding in MASI has fallen by USD 26,330 compared to the previous valuation of Masimo Corporation |
| MDT - Medtronic PLC | HOLD | 0 @ USD 101.97 | USD 0 | The current share valuation price of MDT based on adjusted close was USD 101.97. The average price that MDT shares were previous bought at was USD 89.4904. The current market price is 13.9% higher than average price they were purchased at. The value of the holding in MDT has fallen by USD 10,708 compared to the previous valuation of Medtronic PLC |
| NVCR - Novocure Ltd | HOLD | 0 @ USD 11.81 | USD 0 | The current share valuation price of NVCR based on adjusted close was USD 11.81. The average price that NVCR shares were previous bought at was USD 17.8097. The current market price is -33.7% lower than average price they were purchased at. The value of the holding in NVCR has increased by USD 12,636 compared to the previous valuation of Novocure Ltd however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| NVST - Envista Holdings Corp | HOLD | 0 @ USD 20.45 | USD 0 | The current share valuation price of NVST based on adjusted close was USD 20.45. The average price that NVST shares were previous bought at was USD 19.1276. The current market price is 6.9% higher than average price they were purchased at. The value of the holding in NVST has increased by USD 6,328 compared to the previous valuation of Envista Holdings Corp however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| OFIX - Orthofix Medical Inc | HOLD | 0 @ USD 15.92 | USD 0 | The current share valuation price of OFIX based on adjusted close was USD 15.92. The average price that OFIX shares were previous bought at was USD 15.4031. The current market price is 3.4% higher than average price they were purchased at. The value of the holding in OFIX has increased by USD 1,028 compared to the previous valuation of Orthofix Medical Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| OMCL - Omnicell Inc | HOLD | 0 @ USD 40.48 | USD 0 | The current share valuation price of OMCL based on adjusted close was USD 40.48. The average price that OMCL shares were previous bought at was USD 34.6291. The current market price is 16.9% higher than average price they were purchased at. The value of the holding in OMCL has increased by USD 13,067 compared to the previous valuation of Omnicell Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| PEN - Pennant International Group plc | HOLD | 0 @ USD 285.71 | USD 0 | The current share valuation price of PEN based on adjusted close was USD 285.71. The average price that PEN shares were previous bought at was USD 259.671. The current market price is 10.0% higher than average price they were purchased at. The value of the holding in PEN has fallen by USD 10,906 compared to the previous valuation of Pennant International Group plc |
| PEN - PBF Energy Inc | HOLD | 0 @ USD 285.71 | USD 0 | The current share valuation price of PEN based on adjusted close was USD 285.71. The average price that PEN shares were previous bought at was USD 259.671. The current market price is 10.0% higher than average price they were purchased at. The value of the holding in PEN has fallen by USD 10,906 compared to the previous valuation of PBF Energy Inc |
| PODD - Insulet Corporation | HOLD | 0 @ USD 307.56 | USD 0 | The current share valuation price of PODD based on adjusted close was USD 307.56. The average price that PODD shares were previous bought at was USD 293.253. The current market price is 4.9% higher than average price they were purchased at. The value of the holding in PODD has fallen by USD 14,126 compared to the previous valuation of Insulet Corporation |
| PRCT - Procept Biorobotics Corp | HOLD | 0 @ USD 33.18 | USD 0 | The current share valuation price of PRCT based on adjusted close was USD 33.18. The average price that PRCT shares were previous bought at was USD 59.3385. The current market price is -44.1% lower than average price they were purchased at. The value of the holding in PRCT has increased by USD 28,138 compared to the previous valuation of Procept Biorobotics Corp however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| LIVN - LivaNova PLC | HOLD | 0 @ USD 63.29 | USD 0 | The current share valuation price of LIVN based on adjusted close was USD 63.29. The average price that LIVN shares were previous bought at was USD 46.7757. The current market price is 35.3% higher than average price they were purchased at. The value of the holding in LIVN has fallen by USD 2,922 compared to the previous valuation of LivaNova PLC |
| RMD - ResMed Inc | HOLD | 0 @ USD 251.44 | USD 0 | The current share valuation price of RMD based on adjusted close was USD 251.44. The average price that RMD shares were previous bought at was USD 244.874. The current market price is 2.7% higher than average price they were purchased at. The value of the holding in RMD has increased by USD 12,047 compared to the previous valuation of ResMed Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| SIBN - Si-Bone Inc | HOLD | 0 @ USD 19.18 | USD 0 | The current share valuation price of SIBN based on adjusted close was USD 19.18. The average price that SIBN shares were previous bought at was USD 15.3583. The current market price is 24.9% higher than average price they were purchased at. The value of the holding in SIBN has fallen by USD 1,221 compared to the previous valuation of Si-Bone Inc |
| STE - STERIS plc | HOLD | 0 @ USD 259.4 | USD 0 | The current share valuation price of STE based on adjusted close was USD 259.4. The average price that STE shares were previous bought at was USD 229.731. The current market price is 12.9% higher than average price they were purchased at. The value of the holding in STE has increased by USD 1,369 compared to the previous valuation of STERIS plc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| SYK - Stryker Corporation | HOLD | 0 @ USD 365.95 | USD 0 | The current share valuation price of SYK based on adjusted close was USD 365.95. The average price that SYK shares were previous bought at was USD 374.8. The current market price is -2.4% lower than average price they were purchased at. The value of the holding in SYK has fallen by USD 34,986 compared to the previous valuation of Stryker Corporation |
| TFX - Teleflex Incorporated | HOLD | 0 @ USD 119.12 | USD 0 | The current share valuation price of TFX based on adjusted close was USD 119.12. The average price that TFX shares were previous bought at was USD 142.319. The current market price is -16.3% lower than average price they were purchased at. The value of the holding in TFX has increased by USD 18,125 compared to the previous valuation of Teleflex Incorporated however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| TMCI - Treace Medical Concepts Inc | HOLD | 0 @ USD 2.67995 | USD 0 | The current share valuation price of TMCI based on adjusted close was USD 2.67995. The average price that TMCI shares were previous bought at was USD 7.60423. The current market price is -64.8% lower than average price they were purchased at. The value of the holding in TMCI has fallen by USD 121 compared to the previous valuation of Treace Medical Concepts Inc |
| TMDX - TransMedics Group Inc | HOLD | 0 @ USD 140.1 | USD 0 | The current share valuation price of TMDX based on adjusted close was USD 140.1. The average price that TMDX shares were previous bought at was USD 93.1357. The current market price is 50.4% higher than average price they were purchased at. The value of the holding in TMDX has fallen by USD 7,918 compared to the previous valuation of TransMedics Group Inc |
| TNDM - Tandem Diabetes Care Inc | HOLD | 0 @ USD 19.93 | USD 0 | The current share valuation price of TNDM based on adjusted close was USD 19.93. The average price that TNDM shares were previous bought at was USD 20.954. The current market price is -4.9% lower than average price they were purchased at. The value of the holding in TNDM has increased by USD 3,000 compared to the previous valuation of Tandem Diabetes Care Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| VREX - Varex Imaging Corp | HOLD | 0 @ USD 11.46 | USD 0 | The current share valuation price of VREX based on adjusted close was USD 11.46. The average price that VREX shares were previous bought at was USD 11.354. The current market price is 0.9% higher than average price they were purchased at. The value of the holding in VREX has increased by USD 719 compared to the previous valuation of Varex Imaging Corp however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| ZBH - Zimmer Biomet Holdings Inc | HOLD | 0 @ USD 93.1 | USD 0 | The current share valuation price of ZBH based on adjusted close was USD 93.1. The average price that ZBH shares were previous bought at was USD 102.164. The current market price is -8.9% lower than average price they were purchased at. The value of the holding in ZBH has fallen by USD 28,772 compared to the previous valuation of Zimmer Biomet Holdings Inc |
| EW - Edwards Lifesciences Corp | HOLD | 0 @ USD 83.98 | USD 0 | The current share valuation price of EW based on adjusted close was USD 83.98. The average price that EW shares were previous bought at was USD 73.2429. The current market price is 14.7% higher than average price they were purchased at. The value of the holding in EW has fallen by USD 59,672 compared to the previous valuation of Edwards Lifesciences Corp |
| AORT - Artivion Inc | HOLD | 0 @ USD 45.48 | USD 0 | The current share valuation price of AORT based on adjusted close was USD 45.48. The average price that AORT shares were previous bought at was USD 34.7351. The current market price is 30.9% higher than average price they were purchased at. The value of the holding in AORT has increased by USD 635 compared to the previous valuation of Artivion Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| ATEC - Alphatec Holdings Inc | HOLD | 0 @ USD 21.23 | USD 0 | The current share valuation price of ATEC based on adjusted close was USD 21.23. The average price that ATEC shares were previous bought at was USD 13.2192. The current market price is 60.6% higher than average price they were purchased at. The value of the holding in ATEC has increased by USD 951 compared to the previous valuation of Alphatec Holdings Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| ATRC - AtriCure Inc | HOLD | 0 @ USD 36.31 | USD 0 | The current share valuation price of ATRC based on adjusted close was USD 36.31. The average price that ATRC shares were previous bought at was USD 35.4391. The current market price is 2.5% higher than average price they were purchased at. The value of the holding in ATRC has increased by USD 6,897 compared to the previous valuation of AtriCure Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| AXGN - Axogen Inc | HOLD | 0 @ USD 28.33 | USD 0 | The current share valuation price of AXGN based on adjusted close was USD 28.33. The average price that AXGN shares were previous bought at was USD 18.2722. The current market price is 55.0% higher than average price they were purchased at. The value of the holding in AXGN has increased by USD 4,218 compared to the previous valuation of Axogen Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| BAX - Baxter International Inc | HOLD | 0 @ USD 18.89 | USD 0 | The current share valuation price of BAX based on adjusted close was USD 18.89. The average price that BAX shares were previous bought at was USD 27.4613. The current market price is -31.2% lower than average price they were purchased at. The value of the holding in BAX has increased by USD 3,566 compared to the previous valuation of Baxter International Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| BDX - Becton Dickinson and Company | HOLD | 0 @ USD 193.57 | USD 0 | The current share valuation price of BDX based on adjusted close was USD 193.57. The average price that BDX shares were previous bought at was USD 201.916. The current market price is -4.1% lower than average price they were purchased at. The value of the holding in BDX has increased by USD 123,771 compared to the previous valuation of Becton Dickinson and Company however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| BSX - Boston Scientific Corporation | HOLD | 0 @ USD 98.57 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 98.57. The average price that BSX shares were previous bought at was USD 98.196. The current market price is 0.4% higher than average price they were purchased at. The value of the holding in BSX has fallen by USD 92,879 compared to the previous valuation of Boston Scientific Corporation |
| BSX - MULSTRXSSXIMETFP | HOLD | 0 @ USD 98.57 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 98.57. The average price that BSX shares were previous bought at was USD 98.196. The current market price is 0.4% higher than average price they were purchased at. The value of the holding in BSX has fallen by USD 92,879 compared to the previous valuation of MULSTRXSSXIMETFP |
| CNMD - CONMED Corporation | HOLD | 0 @ USD 44.35 | USD 0 | The current share valuation price of CNMD based on adjusted close was USD 44.35. The average price that CNMD shares were previous bought at was USD 56.641. The current market price is -21.7% lower than average price they were purchased at. The value of the holding in CNMD has increased by USD 1,363 compared to the previous valuation of CONMED Corporation however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| DXCM - DexCom Inc | HOLD | 0 @ USD 64.85 | USD 0 | The current share valuation price of DXCM based on adjusted close was USD 64.85. The average price that DXCM shares were previous bought at was USD 75.1618. The current market price is -13.7% lower than average price they were purchased at. The value of the holding in DXCM has increased by USD 21,809 compared to the previous valuation of DexCom Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| ENOV - Enovis Corp | HOLD | 0 @ USD 29.28 | USD 0 | The current share valuation price of ENOV based on adjusted close was USD 29.28. The average price that ENOV shares were previous bought at was USD 36.4594. The current market price is -19.7% lower than average price they were purchased at. The value of the holding in ENOV has fallen by USD 806 compared to the previous valuation of Enovis Corp |
| ABT - Abbott Laboratories | HOLD | 0 @ USD 125.29 | USD 0 | The current share valuation price of ABT based on adjusted close was USD 125.29. The average price that ABT shares were previous bought at was USD 128.644. The current market price is -2.6% lower than average price they were purchased at. The value of the holding in ABT has fallen by USD 249,706 compared to the previous valuation of Abbott Laboratories |
| GEHC - GE HealthCare Technologies Inc. | HOLD | 0 @ USD 83.59 | USD 0 | The current share valuation price of GEHC based on adjusted close was USD 83.59. The average price that GEHC shares were previous bought at was USD 74.8934. The current market price is 11.6% higher than average price they were purchased at. The value of the holding in GEHC has increased by USD 214,601 compared to the previous valuation of GE HealthCare Technologies Inc. however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| GKOS - Glaukos Corp | HOLD | 0 @ USD 107.46 | USD 0 | The current share valuation price of GKOS based on adjusted close was USD 107.46. The average price that GKOS shares were previous bought at was USD 106.937. The current market price is 0.5% higher than average price they were purchased at. The value of the holding in GKOS has increased by USD 11,044 compared to the previous valuation of Glaukos Corp however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| GMED - Globus Medical | HOLD | 0 @ USD 87.75 | USD 0 | The current share valuation price of GMED based on adjusted close was USD 87.75. The average price that GMED shares were previous bought at was USD 70.2905. The current market price is 24.8% higher than average price they were purchased at. The value of the holding in GMED has fallen by USD 20,142 compared to the previous valuation of Globus Medical |
| HOLX - Hologic Inc | HOLD | 0 @ USD 75.01 | USD 0 | The current share valuation price of HOLX based on adjusted close was USD 75.01. The average price that HOLX shares were previous bought at was USD 67.0007. The current market price is 12.0% higher than average price they were purchased at. The value of the holding in HOLX has increased by USD 5,885 compared to the previous valuation of Hologic Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| IART - Integra LifeSciences Holdings | HOLD | 0 @ USD 13.49 | USD 0 | The current share valuation price of IART based on adjusted close was USD 13.49. The average price that IART shares were previous bought at was USD 17.8768. The current market price is -24.5% lower than average price they were purchased at. The value of the holding in IART has increased by USD 3,061 compared to the previous valuation of Integra LifeSciences Holdings however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| IDXX - IDEXX Laboratories Inc | HOLD | 0 @ USD 725.93 | USD 0 | The current share valuation price of IDXX based on adjusted close was USD 725.93. The average price that IDXX shares were previous bought at was USD 509.311. The current market price is 42.5% higher than average price they were purchased at. The value of the holding in IDXX has fallen by USD 75,786 compared to the previous valuation of IDEXX Laboratories Inc |
| INSP - Inspirit Energy Holdings Plc | HOLD | 0 @ USD 134.75 | USD 0 | The current share valuation price of INSP based on adjusted close was USD 134.75. The average price that INSP shares were previous bought at was USD 135.25. The current market price is -0.4% lower than average price they were purchased at. The value of the holding in INSP has increased by USD 3,068 compared to the previous valuation of Inspirit Energy Holdings Plc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| IRTC - iRhythm Technologies Inc | HOLD | 0 @ USD 183.04 | USD 0 | The current share valuation price of IRTC based on adjusted close was USD 183.04. The average price that IRTC shares were previous bought at was USD 129.4. The current market price is 41.5% higher than average price they were purchased at. The value of the holding in IRTC has increased by USD 5,241 compared to the previous valuation of iRhythm Technologies Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| ISRG - Intuitive Surgical Inc | HOLD | 0 @ USD 569.71 | USD 0 | The current share valuation price of ISRG based on adjusted close was USD 569.71. The average price that ISRG shares were previous bought at was USD 510.011. The current market price is 11.7% higher than average price they were purchased at. The value of the holding in ISRG has increased by USD 99,366 compared to the previous valuation of Intuitive Surgical Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| ITGR - Integer Holdings Corp | HOLD | 0 @ USD 69.88 | USD 0 | The current share valuation price of ITGR based on adjusted close was USD 69.88. The average price that ITGR shares were previous bought at was USD 117.637. The current market price is -40.6% lower than average price they were purchased at. The value of the holding in ITGR has fallen by USD 533 compared to the previous valuation of Integer Holdings Corp |